Optical Pretargeting of Tumor with Fluorescent MORF Oligomers
Tóm tắt
Pretargeting with radioactivity has significantly improved tumor to normal tissue radioactivity ratios over conventional antibody imaging in both animal studies and clinical trials. This laboratory is investigating DNA analogues such as phosphorodiamidate morpholinos (MORFs) for pretargeting using technetium-99m (99mTc) for detection. However, the unique properties of fluorescence activation and quenching combined with oligomers with their unique properties of hybridization may be particularly useful when used together for pretargeting with optical detection. The use of linear fluorophore-conjugated oligomer duplexes have been little used in animals, and to our knowledge, have not previously been considered for pretargeting applications. A MORF/cDNA pair was selected such that when hybridized, the fluorescence of the Cy5.5-conjugated 25 mer MORF (Cy5.5–MORF25) is inhibited with a BHQ3-conjugated 18 mer complementary DNA (BHQ3–cDNA18). The short BHQ3–cDNA18 was selected to dissociate in the presence of a long cMORF25 in the pretargeted tumor, thus releasing the inhibitor from the Cy5.5 emitter. In this manner, the Cy5.5 fluorescence will be inhibited everywhere but in the target. The dissociation was first examined in vitro by adding the duplex to the cMORF25 both in solution and immobilized on polystyrene microspheres and by surface plasmon resonance (SPR). Thereafter, biotinylated cMORF25 immobilized on streptavidin polystyrene microspheres were administered intramuscularly in one thigh of hairless SKH-1 mice as target while an identical weight of the identical microspheres but without the cMORF25 was administered in the contralateral thigh as control. The animals then received IV the Cy5.5–MORF25/BHQ3–cDNA18 duplex or equal molar dosage of single-chain Cy5.5–MORF25 and were imaged. The SPR studies showed that the immobilized cDNA18 rapidly captured the flowing MORF25 to provide a duplex with a slow dissociation rate constant. Furthermore, when cMORF25 was next allowed to flow over the now immobilized duplex, the cDNA18 was unable to prevent dissociation of the heteroduplex and the formation and release of the cMORF25-MORF25 homoduplex. Images of animals obtained soon after receiving the Cy5.5–MORF25 singlet showed intense whole body fluorescence obscuring the target thigh. However, only 5 minutes after receiving the Cy5.5–MORF25/BHQ3–cDNA18 duplex, the target thigh was clearly visible along with only the kidneys. This first study of optical pretargeting provides a proof of concept that oligomer pretargeting found to be useful with radioactivity detection is applicable with fluorescent detection as well. In addition, our results demonstrate that by using linear oligomers for optical pretargeting, chain lengths (and base sequences) may be manipulated to provide duplexes with stabilities and fluorescence inhibition optimized for pretargeting and other in vivo applications of optical imaging.
Tài liệu tham khảo
Ke S, Wen X, Gurfinkel M, et al. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63:7870–7875
Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13:195–208
Emptage NJ (2001) Fluorescent imaging in living systems. Curr Opin Pharmacol 1:521–525
McIntyre JO, Fingleton B, Wells KS, et al. (2004) Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J 377:617–628
Molenaar C, Marras SA, Slats JC, et al. (2001) Linear 2’ O-methyl RNA probes for the visualization of RNA in living cells. Nucleic Acids Res 29:E89–E89
Tyagi S, Alsmadi O (2004) Imaging native b-actin mRNA in motile fibroblasts. Biophys J 87:4153–4162
Cheng Z, Wu Y, Xiong Z, et al. (2005) Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug Chem 16:1433–1441
He J, Liu G, Gupta S, et al. (2004) Amplification targeting—a modified pretargeting approach with potential for signal amplification—proof of a Concept. J Nucl Med 45:1087–1095
He J, Liu XR, Zhang SR, et al. (2005) Affinity enhancement bivalent morpholino for pretargeting: Surface Plasmon Resonance Studies of Molecular Dimensions. Bioconjug Chem 16:1098–1104
He J, Liu G, Zhang SR, et al. (2003) A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length. Bioconjug Chem 14:1018–1023
Moon WK, Lin Y, O’Loughlin T, et al. (2003) Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 14:539–545
Chen CS, Elias M, Busam K, et al. (2005) Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma. Br J Dermatol 153:1031–1036
Houston JP, Ke S, Wang W, et al. (2005) Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt 10:054010
Bloch S, Lesage F, McIntosh L, et al. (2005) Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice. J Biomed Opt 10:054003
Zheleznaya LA, Kopein DS, Rogulin EA, et al. (2006) Significant enhancement of fluorescence on hybridization of a molecular beacon to a target DNA in the presence of a site-specific DNA nickase. Anal Biochem 348:123–126
Liu G, He J, Dou S, et al. (2004) Pretargeting in tumored mice with radiolabeled cytosine-free morpholino oligomers. Eur J Nucl Med 31:417–424
Zhang Y, He J, Liu G, et al. (2004) Initial observations of 99mTc-labeled locked nucleic acids for antisense targeting. Nucl Med Common 25:1113–1118
Ballou B, Fisher GW, Deng JS, et al. (1998) Cyanine fluorochrome-labeled antibodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. Cancer Detect Prev 22:251–257
Weissleder R, Tung CH, Mahmood U, et al. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375–378
Petrovsky A, Schellenberger E, Josephson L, et al. (2003) Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 63:1936–1942